1.
J Natl Compr Canc Netw
; 10(10): 1203-6, 2012 Oct 01.
Artículo
en Inglés
| MEDLINE
| ID: mdl-23054874
RESUMEN
This case report presents a patient with poor-prognosis chronic lymphocytic leukemia (CLL) who was treated with chemotherapy and underwent allogeneic hematopoietic cell transplant (alloHCT) but ultimately progressed. The application of the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for CLL and the impact of alloHCT on secondary therapy for progressive CLL are discussed.